Table V.

Delivery Unit Cost of Prevention of Mother to Child Transmission of HIV

Country	Reference	City/Setting Costing year	Scope		Provider type	PMTCT unit cost (2009USD)	Cost in 2009 USD (% of total cost)				Regimen
			Facilities	Patients			ARV drugs	Personnel	Laboratory tests	Overheads
India	Dandona L, et al. 2008 [46]	Andhra Pradesh/U2005–06	16	1,212ϒ	Nat	2.4 Post test counseling	Included but not unbundled	1.1 (47.3%)	Included but not unbundled	0.35 (14.7%)	NVP
						251.1# Mother neonate pair receiving nevirapine		118.7 (47.3%)		36.9 (14.7%)
South Africa	Desmond C, et al. 2004 [47]	Durban/U; Paarl/U; Siloam/R Frankfort/R; 2002	9	709	Nat/D	42.4 Pretest counseling	Included but not unbundled	Included but not unbundled	Included but not unbundled	Not included	NVP + CTX
				570		32.5 Testing
				532		23.8 Post test counseling
				117ϒ		208.8¥ Mother neonate pair receiving nevirapine
				63		327.2‡ Mother neonate pair follow up
Rwanda	McMennamin T, Fellow A. 2007 [48]	Gicumbi/R 2005	6	NA	Nat/FBO	6.42 Specific intervention	Included but not unbundled	Included but not unbundled	Included but not unbundled	Included but not unbundled	Not reported

NA: not available in the study

Costs have been converted into USD$ of 2009 using average exchange rates during the study period

City/setting: Refers to the city and the type of location: U= Urban; R= Rural

Costing year: Refers to the year for which the study reported the costs

Facilities: Refers to the number of facilities in which the costs were collected

Patients: Refers to the number of patients studied to cost the ART delivery:

^ϒmother-neonate pairs

Provider type: Refers to the type of ART provider: Nat=National; D=Donor; NGO= Non-government organization ; FBO= Faith based organization

Regimen: ARV line costed by the study using acronyms for ARV drugs taken from the World Health Organization classification: Cotrimoxazole = CTX; Nevirapine = NVP

^#The mother was given one tablet of 200 mg at the onset of labor and the neonate was given 2 mg/kg body weight within 72 hours of birth.

^¥This cost includes re-issue of nevirapine to mothers, and provision of nevirapine suspension to the child and any formula milk for the duration of the hospital stay.

^‡PMTCT activities delivered after the mother and infant are discharged from hospital after delivery, including cotrimoxazole and the provision of formula feeding. It does not include infant HIV testing.